About
Care and conscience are
the core of our corporate values
more
the core of our corporate values
04 Jan,2024
Zylox-Tonbridge’s ZYLOX® Phoenix Peripheral Detachable Fibered Coil Embolization System Receives NMPA Marketing Approval
Zylox-Tonbridge Medical Technology Co., Ltd. (2190.HK, hereinafter referred to as "Zylox-Tonbridge" or the "Company") announced that its ZYLOX® Phoenix Peripheral Detachable Fiber...
more
21 Dec,2023
Zylox-Tonbridge Completed Patient Enrollment for ZENFLEX® Peripheral Stent System Clinical Trial in the EU
December 18, 2023. Zylox-Tonbridge (2190. HK, "the Company"), a leading vascular interventional medical device manufacturer in China, announced the completion of the total enrollment of 100 ...
more
06 Dec,2023
The 2023 Investor Open Day of Zylox-Tonbridge was successfully held
On November 29th, the 2023 Investor Open Day of Zylox-Tonbridge ("2190. HK", hereinafter referred to as "the Company") was successfully held in Hangzhou, China. The event attracted...
more
18 Sep,2023
Zylox-Tonbridge was Added to the FTSE Global Equity Index Series
Zylox-Tonbridge (2190.HK, "the Company") is pleased to learn that the Company's stock was added to the FTSE Global Equity Index Series ("GEIS"), including FTSE Global Total-Cap...
more
31 Aug,2023
Zylox-Tonbridge’s ZENFlow Tiger™ LD PTA Dilatation Catheter Receives ANVISA Marketing Approval
Zylox-Tonbridge Medical Technology Co., Ltd. (2190.HK, hereinafter referred to as "Zylox-Tonbridge" or the "Company") announced that its ZENFlow Tiger™ LD PTA Dilatation Catheter ...
more
28 Aug,2023
Zylox-Tonbridge Reveals 2023 Interim Financial Results: Revenue Surges 50.7% YOY to 230 Million Yuan, Gross Profit Climbs to 171 Million Yuan
On August 23rd, 2023, Zylox-Tonbridge Medical Technology Co., Ltd. (2190.HK, hereinafter referred to as "Zylox-Tonbridge" or the "Company") released its financial results for the f...
more
